9 minutes | Jul 23rd 2018

161 – Ivosidenib for AML; Mobile Cardiac Rehabilitation System; AGN-241751 for MDD; Senseonics Implantable Glucose Sensor; Essure withdrawal

July 23, 2018 Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com FDA approves first targeted treatment for patients with relapsed or refractory acute myeloid leukemia who have a certain genetic mutation https://www.prnewswire.com/news-releases/fda-approves-first-targeted-treatment-for-patients-with-relapsed-or-refractory-acute-myeloid-leukemia-who-have-a-certain-genetic-mutation-300684317.html MEDICALgorithmics, Medi-Lynx Receive FDA 510(K) Clearance for PocketECG CRS Mobile Cardiac Rehabilitation System https://www.prnewswire.com/news-releases/medicalgorithmics-medi-lynx-receive-fda-510k-clearance-for-pocketecg-crs-mobile-cardiac-rehabilitation-system-300684623.html  Allergan Receives FDA Fast Track Designation for AGN-241751 for the Treatment of Major Depressive Disorder (MDD) https://www.prnewswire.com/news-releases/allergan-receives-fda-fast-track-designation-for-agn-241751-for-the-treatment-of-major-depressive-disorder-mdd-300684622.html IDT's Customer Senseonics Receives FDA Approval for its Implantable Glucose Sensor https://www.prnewswire.com/news-releases/idts-customer-senseonics-receives-fda-approval-for-its-implantable-glucose-sensor-300684424.html Statement from FDA Commissioner Scott Gottlieb, M.D., on manufacturer announcement to halt Essure sales in the U.S.; agency’s continued commitment to postmarket review of Essure and keeping women informed https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm614123.htm New courses on Udemy.com. If you type in “Emma Nichols”, you’ll pull up my courses. The latest ones are Cancer Biology 101, How to Read and Interpret a Scientific Paper, and Freelance Medical Writing as a Career Choice. To check those out, just go to Udemy.com (Udemy.com) and type in “Emma Nichols” to pull them up.
Play Next